The results come as Bristol Myers moves to cut $1.5 billion in costs by 2025 and reinvest that money into key drug brands and research and development programs.
Bristol Myers Squibb beats earnings estimates, raises outlook as drugmaker slashes costs
Categories:
Related Post
Why the CDC is warning that this flu season is on track to be one of the worst in a decadeWhy the CDC is warning that this flu season is on track to be one of the worst in a decade
With at least 33 million cases, 430,000 hospitalizations, and 19,000 deaths, this year’s flu season is proving severe. CBS News Chief medical correspondent Dr. Jon LaPook weighs in on the
Kevin Costner says making movies has ‘nothing to do with politics’Kevin Costner says making movies has ‘nothing to do with politics’
Kevin Costner shared his view that American politics shouldn’t have any impact on how Hollywood movies are made. Ahead of taking office on Jan. 20, President Donald Trump named Sylvester
Musk’s demand that fed employees list their accomplishments roils workforce: ‘Mass civil disobedience’Musk’s demand that fed employees list their accomplishments roils workforce: ‘Mass civil disobedience’
Department of Government Efficiency chair Elon Musk announced that federal employees must report their accomplishments from the last week or face losing their jobs, which has roiled the federal workforce